港股異動 | 合景泰富(1813.HK)再升超6% 4日連漲近30% 年度業績靚麗
格隆匯3月27日丨合景泰富(1813.HK)今日繼續強勢,4日連漲近30%。現報11.04港元,漲6.15%,暫成交46052港元,最新總市值350.7億港元,合景泰富集團日前公佈,2019年度純利大增143.0%至98.06億元人民幣。於期內公司各項指標呈現上升趨勢。展望2020年,合景泰富集團的年度銷售目標設為1033億,預期較2019年預售額提升20%。格隆匯文章《合景泰富(1813.HK)業績強勁增長,負債可控和財務穩健增添更大確定性》中提到,公司土地儲備優質且充裕,支撐未來銷售規模的持續增長,負債可控和財務穩健。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.